Arcutis Biotherapeutics, Inc.
ARQT
Classificação em ações
#4366
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Preço da ação
$28.54
Última sincronização: 2026-10-16
Valor de mercado
$3.59B
Variação (1 dia)
-1.94%
Variação (1 ano)
36.66%
País
US
Negociar Arcutis Biotherapeutics, Inc. (ARQT)
Categoria
Healthcare
EPS de Arcutis Biotherapeutics, Inc. (ARQT)
EPS em June 2026 TTM: $0.22
De acordo com os últimos relatórios financeiros e o preço das ações da Arcutis Biotherapeutics, Inc., o EPS atual da empresa (TTM) é $0.22. No final de 2023, a empresa teve um EPS de $-3.78, uma diminuição em relação a ao EPS de 2022, que foi de $-5.66.
Histórico de EPS da Arcutis Biotherapeutics, Inc. de 2017 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $0.22 | -118.97% |
| 2024 | $-1.16 | -69.31% |
| 2023 | $-3.78 | -33.22% |
| 2022 | $-5.66 | 35.73% |
| 2021 | $-4.17 | 9.74% |
| 2020 | $-3.80 | 245.45% |
| 2019 | $-1.10 | 107.55% |
| 2018 | $-0.53 | -88.75% |
| 2017 | $-4.71 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $17.32 | 7,772.73% |
US
|
|
| $-7.98 | -3,727.27% |
US
|
|
| $-5.29 | -2,504.55% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 12,509.09% |
NL
|
